Phase II trial of docetaxel: a new, highly effective antineoplastic agent in the management of patients with anthracycline-resistant metastatic breast cancer (Q40677493)
Jump to navigation
Jump to search
scientific article published on December 1995
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase II trial of docetaxel: a new, highly effective antineoplastic agent in the management of patients with anthracycline-resistant metastatic breast cancer |
scientific article published on December 1995 |
Statements
1 reference
Phase II trial of docetaxel: a new, highly effective antineoplastic agent in the management of patients with anthracycline-resistant metastatic breast cancer (English)
1 reference
A U Buzdar
1 reference
V Valero
1 reference
F A Holmes
1 reference
R S Walters
1 reference
R L Theriault
1 reference
L Esparza
1 reference
G Fraschini
1 reference
G A Fonseca
1 reference
R E Bellet
1 reference
G N Hortobagyi
1 reference
1 December 1995
1 reference
1 reference
13
1 reference
12
1 reference
2886-2894
1 reference
Identifiers
1 reference
1 reference